Boehringer Ingelheim International Gmbh

Bayer Intellectual Property Gmbh

Other

Bayer Pharma Aktiengesellschaft

Bayer Healthcare Aktiengesellschaft

Aicuris Gmbh + Co. Kg.

Bayer Schering Pharma Ag

Aicuris Anti-Infective Cures Gmbh

Aicuris Gmbh & Co. Kg

Dagmar Karthaus

Adrian Tersteegen

Martin Hendrix

Lars Bärfacker

Heike Heckroth

Daniel Meibom

Volkhart Min-Jian Li

Klemens Lustig

Martina Delbeck

Franz Von Nussbaum

Marja Van Kampen

Frank-Thorsten Hafner

Sonja Anlauf

Franz-Josef Van Der Staay

Christina Erb

Jens Schamberger

Karl-Heinz Schlemmer

Dieter Lang

Jörg Keldenich

Dirk Schneider

Maria Niewöhner, Legal Representative

Hilmar Bischoff

Rudolf Schohe-Loop

Joachim Schuhmacher

Peter Kolkhof

Carsten Schmeck

Tobias Wunberg

Heinrich Meier

Bernd Riedl

Kerstin Henninger

Ingo Flamme

Elisabeth Pook

Holger Zimmermann

Ulrich Ebert

Chantal Fürstner

Cristina Alonso-Alija

Mary F Fitzgerald

Nils Burkhardt

Frank Mauler

Niels Svenstrup

Ulf Brüggemeier

Heike Gielen-Haertwig

Graham Sturton

Daniela Paulsen

Nigel J Cuthbert

Dirk Heimbach

Arno Friedl

Volker Geiss

Eckhard Bender

Irene Gerlach

Özkan Yalkinoglu

Bettina Beyreuther

Martin Michels

Volker Hinz

Verena Voehringer

Andreas Goeller

David Brückner

Christine Erb

Yan-Hong Liu

The present invention relates to novel heterocyclically fused diaryldihydropyrimidine derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system.

Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD

The present invention relates to novel 4-(4-cyano-2-thioaryl)dihydropyrimidin-2-one derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system.

4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof

4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use

The invention relates to 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines, process for their preparation, and their use for producing medicaments for improving learning and/or memory. The 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines are of the formula (I): with the variables as defined in the claims.

6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines

The invention relates to novel 6-arylmethyl-substituted pyrazolopyrimidines, process for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory.

6-arylmethyl substituted pyrazolo[3,4-d]pyrimidines

The present application relates to novel sulfonamide- or sulfoximine-substituted 1,4-diaryldihydropyrimidin-2-one derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system.

Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof

The invention relates to novel 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines, process for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory. The pyrazolopyrimidine compounds are within the formula (I) 

The present invention relates to novel 1,4-diarylpyrimido[4,5-d]pyridazine-2,5-dione derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system.

1,4-diaryl-pyrimidopyridazine-2,5-diones and their use

The invention relates to novel cyanopyrimidinones, process for their preparation, and the use thereof for producing medicaments for improving perception, concentration, learning and/or memory.

Cyanopyrimidinones

The invention relates to substituted arylsulfonamides of formula (I) and methods for their preparation as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, particularly against cytomegaloviruses. 

Substituted arylsulfonamides as antiviral agents

The present application relates to novel, substituted 4-arylimidazol-2-ones and 5-aryl-1,2,4-triazolones, processes for the production thereof, the use thereof alone or in combinations for the treatment and/or prevention of diseases and the use thereof for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular diseases.

Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors

Described are 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolo[3,4-d]pyrimidines of the formula (I): as defined herein, processes for their preparation and their use for producing medicaments for treating impairment of perception, concentration, learning and/or memory.

6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory

Growing community of inventors

Solingen, Germany

Dagmar Karthaus